|Published||Report Code||Available Format||Pages|
The global external defibrillator market size was $3,926.5 million in 2019, and it is projected to witness a CAGR of 8.5% during the forecast period (2020–2030). The rising elderly population, technological advancements in automated external defibrillators (AEDs), and increasing focus of market players to engage in strategic development activities are the key growth factors driving the external defibrillator industry.
In 2019, the non-wearable bifurcation accounted for the larger size in the external defibrillator market, on the basis of type. This was mainly because of the rising incidence of cardiac diseases across the globe and wide use of external defibrillators to treat irregular heart rhythms. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the number one cause of death, taking approximately 17.9 million lives each year. It has been observed that the majority of CVD deaths are caused by coronary heart disease (CHD), followed by stroke and heart failure, thereby leading to the increasing adoption of external defibrillators, worldwide.
The automatic bifurcation held the dominating share in the external defibrillator market in 2019, on the basis of technology. The bifurcation is also projected to witness faster growth as compared to the manual bifurcation in the coming years. This is ascribed to the fact that automatic defibrillators do not specifically require technical expertise for operation, and they are being increasingly installed in public settings, such as airports, gyms, shopping malls, schools, and sports complexes. Furthermore, a number of market players are developing AEDs to manage the condition sudden cardiac arrest (SCA).
The adult bifurcation is projected to grow at a higher rate than pediatric patients, in the external defibrillator industry. This is mainly because the occurrence of SCAs is more common in adult patients suffering from CVDs, which may also lead to the death of the patient. For instance, according to the Heart Rhythm Clinic of Michigan (HRCM), sudden cardiac death (SCD) causes about 325,000 adult deaths in the U.S. each year, thereby increasing the demand for external defibrillators significantly.
Public-access settings were the largest end users of external defibrillators and related products in 2019. The category is further expected to hold the largest share in the external defibrillator market during the forecast years. The increasing adoption of technologically advanced products, surging prevalence of chronic CVDs, rising number of awareness campaigns and conferences conducted by public and private organizations, and improving healthcare infrastructure are some of the factors contributing to the market growth.
During the historical period (2014–2019), North America held the largest share in external defibrillator market, due to the rising healthcare spending, increasing prevalence of CVDs, surging geriatric population, and growing awareness on the benefits of AEDs, in the event of ventricular fibrillation (VF) and pulseless ventricular tachycardia.
Further, governments are promoting the use of external defibrillators; for instance, the U.S. government spends a significant portion of its gross domestic product (GDP) on healthcare, every year. The National Health Expenditure Accounts (NHEA) reported that the country’s healthcare expenditure grew by 3.9% from 2016, to reach $3.5 trillion in 2017. Furthermore, according to the NHEA, the country’s healthcare spending is projected to increase further and reach $6.0 trillion by 2027, registering a CAGR of 5.5% during 2018–2027.
COVID-19 is having a negative impact on the global external defibrillator market. Due to this pandemic, the outlook for the industry has changed significantly, with the demand for defibrillators predicted to decrease in the short run, across the globe. This will be overcome by the proper lifting of lockdowns and resumption of import and export activities, worldwide.
The prominent trend in the external defibrillator market is the shifting focus from implantable devices to external defibrillators. Despite high implantable cardioverter defibrillator (ICD) usage in patients at a high risk of sustained or recurrent arrhythmias, the use of AEDs is gaining popularity, especially for older patients, who cannot undergo heart surgeries.
Several advancements have been reported in the defibrillation technology, over the past few decades. For instance, ZOLL Medical Corporation’s LifeVest is a lightweight wearable defibrillator that can be worn by patients who are at risk of SCA. The LifeVest continuously monitors the patient’s heart, and, in case of an abnormal heart rhythm, the device delivers a shock, to restore the normal sinus rhythm. Similarly, unlike conventional counterparts, modern ICDs have eliminated the need for implanting a separate pacemaker in patients. Such advancements in the technology have positively impacted the growth of the external defibrillator market.
The increasing population of elderly people is another factor driving the external defibrillator market. Globally, the U.S. has the third-fastest-growing geriatric population, after Japan and China. According to the 2018 Population Reference Bureau report, the number of Americans aged 65 years and older is expected to increase two-fold, from 46 million in 2014 to over 98 million by 2060. With increase in age, people tend to become susceptible to chronic diseases, majorly CVDs.
|Base Year (2019) Market Size||$3,926.5 million|
|Forecast Period (2020-2030) CAGR||8.5%|
|Report Coverage||Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies’ Strategical Developments, Product Benchmarking, Company Profiling|
|Market Size by Segments||Type, Technology, Patient Type, End User, Geography|
|Market Size of Geographies||U.S., Canada, Germany, France, Italy, U.K., Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Poland, Ireland, Japan, China, India, Australia, South Korea, Thailand, Brazil, Mexico, Saudi Arabia, South Africa|
|Secondary Sources and References (Partial List)||Centers for Disease Control and Prevention (CDC), Organisation for Economic Co-operation and Development (OECD), World Health Organization (WHO), American Heart Association (AHA), United States Food and Drug Administration (USFDA), Centers for Medicare & Medicaid Services (CMS)|
The external defibrillator market is fragmented in nature, with the presence of market players such as Koninklijke Philips N.V., SCHILLER AG, Nihon Kohden Corporation, Defibtech LLC, Progetti S.r.l., ZOLL Medical Corporation, CU Medical System Inc., Stryker Corporation, and Cardiac Science Corporation.
In recent years, the players in the industry have engaged in strategic developments, such as product launches, in order to stay ahead of their competitors. For instance:
The external defibrillator market report offers comprehensive market segmentation analysis along with market estimation for the period 2014–2030.
Based on Type
Based on Technology
Based on Patient Type
Based on End User
The global external defibrillator market will exhibit a CAGR of 8.5% during 2020–2030.
The non-wearables devices will be the more-highly-sought-after product type in the external defibrillator industry in future.
The automatic category will exhibit the higher CAGR in the external defibrillator market from 2020 to 2030.
Currently, North America is registering the largest share in the external defibrillator industry.
The external defibrillator market will reach a value of $9,450.3 million by 2030.